Tomas Kirchhoff

6.7k total citations
79 papers, 2.7k citations indexed

About

Tomas Kirchhoff is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Tomas Kirchhoff has authored 79 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 38 papers in Oncology and 29 papers in Genetics. Recurrent topics in Tomas Kirchhoff's work include BRCA gene mutations in cancer (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Immunotherapy and Immune Responses (15 papers). Tomas Kirchhoff is often cited by papers focused on BRCA gene mutations in cancer (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Immunotherapy and Immune Responses (15 papers). Tomas Kirchhoff collaborates with scholars based in United States, Canada and Slovakia. Tomas Kirchhoff's co-authors include Kenneth Offit, Mark E. Robson, Nathan A. Ellis, Luis Blanco, Miguel Garcı́a-Dı́az, José F. Ruiz, Orlando Domı́nguez, Iman Osman, Larry Norton and Helen J. Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Tomas Kirchhoff

77 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Kirchhoff United States 26 1.4k 990 948 594 458 79 2.7k
Patricia A. Shaw Canada 29 976 0.7× 1.1k 1.1× 902 1.0× 623 1.0× 355 0.8× 57 3.0k
Cliff Meldrum Australia 24 1.0k 0.8× 1.1k 1.1× 778 0.8× 789 1.3× 619 1.4× 57 2.6k
Maria Isabel Achatz Brazil 26 1.6k 1.2× 1.6k 1.6× 887 0.9× 1.1k 1.8× 559 1.2× 115 3.2k
Yusuke Nakamura Japan 27 1.5k 1.1× 773 0.8× 355 0.4× 627 1.1× 468 1.0× 84 2.7k
Bethan Powell United States 6 1.8k 1.3× 1.6k 1.7× 708 0.7× 594 1.0× 296 0.6× 10 2.9k
Diane L. Persons United States 29 1.4k 1.0× 1.3k 1.3× 331 0.3× 608 1.0× 398 0.9× 64 3.1k
Sigurður Ingvarsson Iceland 29 2.0k 1.4× 725 0.7× 1.2k 1.2× 905 1.5× 574 1.3× 95 3.1k
Narciso Olvera United States 27 1.1k 0.8× 634 0.6× 338 0.4× 600 1.0× 620 1.4× 44 2.4k
Esther H. Lips Netherlands 30 1.1k 0.8× 1.2k 1.2× 530 0.6× 1.2k 2.1× 481 1.1× 84 2.7k
Mamoru Fukuda Japan 24 1.7k 1.2× 1.1k 1.2× 566 0.6× 535 0.9× 366 0.8× 100 3.1k

Countries citing papers authored by Tomas Kirchhoff

Since Specialization
Citations

This map shows the geographic impact of Tomas Kirchhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Kirchhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Kirchhoff more than expected).

Fields of papers citing papers by Tomas Kirchhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Kirchhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Kirchhoff. The network helps show where Tomas Kirchhoff may publish in the future.

Co-authorship network of co-authors of Tomas Kirchhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Kirchhoff. A scholar is included among the top collaborators of Tomas Kirchhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Kirchhoff. Tomas Kirchhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferguson, Robert, Sonia Dolfi, Daniel J. Tenney, et al.. (2024). Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma. Clinical Cancer Research. 30(19). 4412–4423. 2 indexed citations
2.
Kimono, Diana, et al.. (2024). Predictive and pharmacodynamic biomarkers for combination therapy in stage III-IV melanoma: A Simon phase II trial (NCT03999749).. Journal of Clinical Oncology. 42(23_suppl). 222–222. 1 indexed citations
3.
Ferguson, Robert, Danny Simpson, Gabriele Madonna, et al.. (2023). Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition. European Journal of Cancer. 189. 112923–112923. 6 indexed citations
4.
Ascierto, Paolo A., Carlo Bifulco, Fortunato Ciardiello, et al.. (2021). Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy). Journal of Translational Medicine. 19(1). 238–238. 3 indexed citations
5.
Ascierto, Paolo A., Lisa H. Butterfield, Kirk A. Campbell, et al.. (2021). Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge” (December 4th–5th, 2019, Naples, Italy). Journal of Translational Medicine. 19(1). 13–13. 2 indexed citations
6.
Kirchhoff, Tomas & Robert Ferguson. (2019). Germline Genetics in Immuno-oncology: From Genome-Wide to Targeted Biomarker Strategies. Methods in molecular biology. 2055. 93–117. 6 indexed citations
7.
Giles, Keith M., Danny Simpson, Hua Zhou, et al.. (2018). Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. Journal of Translational Medicine. 16(1). 82–82. 97 indexed citations
8.
Kirchhoff, Tomas, Robert Ferguson, Danny Simpson, et al.. (2017). Germline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response. Annals of Oncology. 28. v407–v408. 4 indexed citations
9.
Vogelsang, Matjaž, Karolina Malecek, Artur Romanchuk, et al.. (2016). The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis. Clinical Cancer Research. 22(13). 3268–3280. 18 indexed citations
10.
Silva, Inês Pires da, Keith M. Giles, Matjaž Vogelsang, et al.. (2015). Identification of a Novel Pathogenic Germline KDR Variant in Melanoma. Clinical Cancer Research. 22(10). 2377–2385. 30 indexed citations
11.
Vogelsang, Matjaž, Melissa Wilson, & Tomas Kirchhoff. (2015). Germline determinants of clinical outcome of cutaneous melanoma. Pigment Cell & Melanoma Research. 29(1). 15–26. 9 indexed citations
12.
Vogelsang, Matjaž, Inês Pires da Silva, Nathaniel H. Fleming, et al.. (2015). Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of Medical Genetics. 52(4). 231–239. 17 indexed citations
13.
Clendenen, Tess V., Wenzhen Ge, Karen L. Koenig, et al.. (2015). Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology. PLoS ONE. 10(8). e0135943–e0135943. 8 indexed citations
14.
Wengrod, Jordan, Eleazar Vega‐Saenz de Miera, Ding Wang, et al.. (2013). PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition. Molecular Cancer Research. 12(3). 433–439. 30 indexed citations
15.
Shang, Shulian, Christine Dominianni, Patrick J. Scanlon, et al.. (2013). Melanoma risk loci as determinants of melanoma recurrence and survival. Journal of Translational Medicine. 11(1). 279–279. 29 indexed citations
16.
Vijai, Joseph, Tomas Kirchhoff, David Gallagher, et al.. (2011). Genetic architecture of prostate cancer in the Ashkenazi Jewish population. British Journal of Cancer. 105(6). 864–869. 9 indexed citations
17.
Kirchhoff, Tomas, Zhang-qun Chen, Bert Gold, et al.. (2009). The 6q22.33 Locus and Breast Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention. 18(9). 2468–2475. 15 indexed citations
18.
Bacolod, Manny D., Shuang Wang, Richard Shattock, et al.. (2008). The Signatures of Autozygosity among Patients with Colorectal Cancer. Cancer Research. 68(8). 2610–2621. 40 indexed citations
19.
Mitra, Nandita, Alex Smith, Shaokun Chuai, et al.. (2004). Localization of Cancer Susceptibility Genes by Genome-wide Single-Nucleotide Polymorphism Linkage-Disequilibrium Mapping. Cancer Research. 64(21). 8116–8125. 11 indexed citations
20.
Zajac, Vladimír, Tomas Kirchhoff, Elaine R. Levy, et al.. (1997). Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma.. PubMed. 5(2). 61–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia A. Shaw Breakdown of academic impact, for papers by Cliff Meldrum Breakdown of academic impact, for papers by Maria Isabel Achatz Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Bethan Powell Breakdown of academic impact, for papers by Diane L. Persons Breakdown of academic impact, for papers by Sigurður Ingvarsson Breakdown of academic impact, for papers by Narciso Olvera Breakdown of academic impact, for papers by Esther H. Lips Breakdown of academic impact, for papers by Mamoru Fukuda
Rankless by CCL
2026